Mechanisms of increased NGF production in vascular smooth muscle of the spontaneously hypertensive rat.

The spontaneously hypertensive rat (SHR) was developed as a genetic model of essential hypertension. In vivo and in vitro evidence demonstrates that vascular smooth muscle cells (VSMCs) from the SHR produce more nerve growth factor (NGF) than the normotensive Wistar-Kyoto (WKY) control strain. This increased NGF production is accompanied by excessive innervation of target tissues in the SHR. In the present study, a sensitive, competitive, quantitative, reverse-transcriptase polymerase chain reaction (C Q RT-PCR) assay is characterized and used to analyze levels of NGF mRNA in cultured VSMCs derived from the SHR and WKY strains as well as bladder tissue. Differences in NGF secretion rates between SHR and WKY VSMCs were partially due to an increased stability of NGF mRNA in SHR VSMCs. Following treatment with platelet-derived growth factor (PDGF) and transforming growth factor-beta (TGF-beta 1) to elevate NGF production, the half-life of the NGF mRNA was 104.5 +/- 18.0 min in SHR VSMCs, compared to only 36.5 +/- 11.6 min in WKY VSMCs. Sequence analysis of the 3' untranslated region (UTR) revealed no strain differences in cis-acting sequences potentially involved in determining mRNA stability. Thus, it seems unlikely to be a 3'UTR mutation that prolongs mRNA lifetime. Rather, differential regulation of an RNA-binding protein may play a role in the abnormal NGF mRNA stability in SHR VSMCs. SHR VSMCs also demonstrate an increased translational efficiency of NGF protein; more NGF protein is synthesized per unit of NGF mRNA. The use of a C Q RT-PCR assay has allowed the determination that abnormal NGF mRNA stabilization as well as altered translational efficiency may contribute to excess NGF synthesis and progressive hypertension in the SHR.

[1]  W. Steers,et al.  Thrombin regulates nerve growth factor secretion from vascular, but not bladder smooth muscle cells , 1997, Cell and Tissue Research.

[2]  R. Head,et al.  NERVE GROWTH FACTOR mRNA CONTENT PARALLELS ALTERED SYMPATHETIC INNERVATION IN THE SPONTANEOUSLY HYPERTENSIVE RAT , 1992, Clinical and Experimental Pharmacology and Physiology.

[3]  C. Brumwell,et al.  Innervation and target tissue interactions differentially regulate acetylcholine receptor subunit mRNA levels in developing neurons in situ , 1995, Neuron.

[4]  D. Creedon,et al.  Nerve Growth Factor Synthesis in Vascular Smooth Muscle , 1991, Hypertension.

[5]  Henry Tauber,et al.  Methods of Enzymology. , 1956 .

[6]  S. Poulsen,et al.  The urinary excretion of epidermal growth factor in the rat is reduced by aprotinin, a proteinase inhibitor , 1990, Regulatory Peptides.

[7]  M. Neeman,et al.  Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes , 1995, Molecular and cellular biology.

[8]  P. Hamet,et al.  Vascular smooth muscle cell hyper‐responsiveness to growth factors in hypertension , 1988, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[9]  E. Nisoli,et al.  Expression of nerve growth factor in brown adipose tissue: implications for thermogenesis and obesity. , 1996, Endocrinology.

[10]  G. Schuler,et al.  GM-CSF and oncogene mRNA stabilities are independently regulated in trans in a mouse monocytic tumor , 1988, Cell.

[11]  M. Greenberg,et al.  Multiple elements in the c-fos protein-coding region facilitate mRNA deadenylation and decay by a mechanism coupled to translation. , 1994, The Journal of biological chemistry.

[12]  J. Malter,et al.  Identification of an AUUUA-specific messenger RNA binding protein. , 1989, Science.

[13]  H. Thoenen,et al.  Comparison between the time course of changes in nerve growth factor protein levels and those of its messenger RNA in the cultured rat iris. , 1986, The Journal of biological chemistry.

[14]  B. Keegan,et al.  Increased epidermal growth factor expression produced by testosterone in the submaxillary gland of female mice is accompanied by changes in poly-A tail length and periodicity. , 1996, Endocrinology.

[15]  R. Stitzel,et al.  Elevated Nerve Growth Factor Levels in Young Spontaneously Hypertensive Rats , 1989, Hypertension.

[16]  G. Shaw,et al.  A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation , 1986, Cell.

[17]  W. Steers,et al.  Nerve growth factor in the urinary bladder of the adult regulates neuronal form and function. , 1991, The Journal of clinical investigation.

[18]  B. Tang,et al.  Nerve growth factor mRNA stability is controlled by a cis-acting instability determinant in the 3'-untranslated region. , 1997, Brain research. Molecular brain research.

[19]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[20]  D. Larhammar,et al.  Rat β‐nerve growth factor sequence and site of synthesis in the adult hippocampus , 1988, Journal of neuroscience research.

[21]  C. Triggle,et al.  Structural and functional consequence of neonatal sympathectomy on the blood vessels of spontaneously hypertensive rats. , 1987, Hypertension.

[22]  C. Thompson,et al.  An inducible cytoplasmic factor (AU-B) binds selectively to AUUUA multimers in the 3' untranslated region of lymphokine mRNA , 1991, Molecular and cellular biology.

[23]  S. Ozawa,et al.  Thyroxine increases the levels of epidermal growth factor messenger ribonucleic acid (EGF mRNA) in the thyroid in vivo, as revealed by quantitative reverse transcription polymerase chain reaction with an internal control EGF mRNA. , 1993, Endocrinology.

[24]  S. Peltz,et al.  Interrelationships of the pathways of mRNA decay and translation in eukaryotic cells. , 1996, Annual review of biochemistry.

[25]  D. Creedon,et al.  Synergistic increase in nerve growth factor secretion by cultured vascular smooth muscle cells treated with injury‐related growth factors , 1997, Journal of neuroscience research.

[26]  Michael J. O'Donovan,et al.  Neurotrophin and neurotrophin receptors in vascular smooth muscle cells. Regulation of expression in response to injury. , 1995, The American journal of pathology.

[27]  E. Southern.  Detection of specific sequences among DNA fragments separated by gel electrophoresis. , 1975, Journal of molecular biology.

[28]  S. Furukawa,et al.  Increased nerve growth factor levels in spontaneously hypertensive rats , 1992, Journal of hypertension.

[29]  H. Thoenen,et al.  Relationship between levels of nerve growth factor (NGF) and its messenger RNA in sympathetic ganglia and peripheral target tissues. , 1984, The EMBO journal.

[30]  B. Hengerer.  A rapid procedure for mRNA extraction from a large number of samples. , 1993, BioTechniques.

[31]  R. Levi‐montalcini,et al.  The nerve growth factor 35 years later. , 1987, Science.

[32]  W. Steers,et al.  ALTERED SIGNALLING IN VASCULAR SMOOTH MUSCLE FROM SPONTANEOUSLY HYPERTENSIVE RATS MAY LINK MEDIAL HYPERTROPHY, VESSEL HYPERINNERVATION AND ELEVATED NERVE GROWTH FACTOR , 1995, Clinical and experimental pharmacology & physiology. Supplement.

[33]  R. Hellweg,et al.  Endogenous levels of nerve growth factor (NGF) are altered in experimental diabetes mellitus: A possible role for NGF in the pathogenesis of diabetic neuropathy , 1990, Journal of neuroscience research.

[34]  S. Pshenichkin,et al.  Okadaic Acid Increases Nerve Growth Factor Secretion, mRNA Stability, and Gene Transcription in Primary Cultures of Cortical Astrocytes (*) , 1995, The Journal of Biological Chemistry.

[35]  F. Pinet,et al.  Renin mRNA quantification using polymerase chain reaction in cultured juxtaglomerular cells. Short-term effects of cAMP on renin mRNA and secretion. , 1993, Circulation research.